Laura Bukavina

Uro Onc- Translational Research Lead @CleClinicUro 🔬 bladder microbiome🧫ImmunoOnc @drexelmedicine @JohnsHopkinsSPH 🇺🇦@EUplatinum associate editor 👦👦👦🐩🐶

[Laura Bukavina @LauraBukavinaMD]

Our European Urology Network is expanding now on @WhatsApp providing you daily quick updates across all of our family of journals on latest pubs, first access to video content 🎥, editorial review . Win free merch 🧢☕️ follow
Now >> https://t.co/bZJtqco01l @EurUrolOpen @EurUrolOncol @EurUrolOncol @EUplatinum

[Laura Bukavina @LauraBukavinaMD]

@justindubinmd great message, unforgettable pants

[Laura Bukavina @LauraBukavinaMD]

@Urodoc46 @BlitzUro @CleClinicUro @MElHusseinMD @samantree Yeah

[Laura Bukavina @LauraBukavinaMD]

5 cm en bloc no problem with a little help from a colorectal snare for extraction and A team @BlitzUro @CleClinicUro .. confirmation of muscle by our @MElHusseinMD using histolog confocal @samantree .. #bladdercancer

[Laura Bukavina @LauraBukavinaMD]

Access to clinical trials is a huge problem in part due to lack of infrastructure support at many hospitals and lack of funding for start up.. particularly on the urology side it requires huge commitment from institutions

[koral shah, md @kor_shah]

Our study is now published in @JAMANetworkOpen!

We mapped 436 bladder cancer clinical trials across US counties and examined associations with incidence, mortality, & social vulnerability. Among 3,145 US counties, 77.3% had no bladder cancer trials! 🧵⬇️
https://t.co/8HWU1Lpq2b

[ClevelandClinicNews @CleClinicNews]

A historic investment in research.
A brighter future for Ohio.

We are celebrating the opening of two new state-of-the-art research buildings on our Main Campus.

The buildings will house more than 700 employees and nearly 30 laboratories.
Read more: https://t.co/7ybOgrpNEf

[Laura Bukavina @LauraBukavinaMD]

About time … biology and guidelines finally align. Fantastic efforts by @IBCG_BladderCA @UroDocAsh @pjhensley11

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Important change in the 2026 @AmerUrological NMIBC Guidelines: all high-grade Ta tumors are now classified as high-risk.

This reduces a long-standing source of heterogeneity in the intermediate-risk group and should improve risk-appropriate treatment for patients, while creating cleaner, more meaningful populations for clinical trials.

Great to see the evidence translate into practice. @IBCG_BladderCA @UrogerliMD @pjhensley11 @AmirHorowitz @mouwlab @spsutkaMD @shilpaonc @AndreaNecchi @LAUrology_NL @karima_oualla @PGrivasMDPhD @marigfern @SpiessPhilippe @UroCancerMD

[Laura Bukavina @LauraBukavinaMD]

Thank you for everything you do for GU research, for the countless hours you dedicate to reviewing for @EUplatinum and for continuing to push our field forward

[European Urology @EUplatinum]

🎉 Congratulations to our September Reviewer of the Month, Prof. @JoshMeeks!

Your commitment to the Platinum Journal keeps us a cut above the rest. Thank you!

[Laura Bukavina @LauraBukavinaMD]

@NazliDizman @DrChoueiri @DanaFarber @montypal @neerajaiims @JenWargoMD @MarkDSiegel1 @YaleIMed @PavlosMsaouel @OncHahn @TDorffOnc @MSznol @MVossMD @AnaVManana what a great mentor-mentee selfie . we need more of these on X

[Laura Bukavina @LauraBukavinaMD]

@richard_waithe @WesleyYipMD

[Anthropic @AnthropicAI]

Today, we're kicking off the first phase of the research preview for Model Hardware Standard (MHS): a new standard for AI agents to safely operate physical equipment in scientific research and advanced manufacturing.

Read more: https://t.co/XQ2y9EW7Af

[Chad Ritch @chadritchmd]

@CleClinicUro_FL @CleClinicUro We’re a growing program with big ambitions and exciting things ahead. 🚀

New people. New ideas. New opportunities to advance urologic care across Florida ☀️

We’re just getting started. 😎🌴

https://t.co/T4m9m9xrjU

[Laura Bukavina @LauraBukavinaMD]

@ryansteinbergmd @AmandaMyersMD @UIowa_urology 👏👏👏👏👏👏👏👏

[Laura Bukavina @LauraBukavinaMD]

@CanDAydogdu @hjwang26 @SeanTMcSweeney @gabrielamdd @ram444367 @mikbaer @AmandaNizamMD @MoningiShalini @cjweight @ChrisWeeMD @PierettiAlberto @rebeccampbell50 @MSindhaniAI @drjkaouk @rabouassalymd @GuzmanTaeris @Uroweb @AmerUrological @IBCG_BladderCA

[Laura Bukavina @LauraBukavinaMD]

@Freyaiiie Depends if you eat the ones you fried or broke

[Laura Bukavina @LauraBukavinaMD]

Interesting read .. lots of questions why ? As number of procedures is ⬆️ autonomy as reported by resident is on the decline particularly in oncology ( 😒 boo)

Female residents reported less autonomy across all domains.. is this a true training disparity or differences how we perceive it❗️

[Gina M. Badalato @GMBadalato]

Great work by @niccolalynch and @eric_giannaris, in collaboration with terrific colleagues, examining national trends in surgical autonomy through chief resident case logs. Important work in surgical education. @JSurgEduc

https://t.co/qWQ9Z1xO2o

[Laura Bukavina @LauraBukavinaMD]

@EUplatinum @brookmans76 @RAlaghehbandan

[Laura Bukavina @LauraBukavinaMD]

@dshoskes @AndreaNecchi @MattGalsky you dont ask a lady about her age or her AI status

[Laura Bukavina @LauraBukavinaMD]

Recently published @AndreaNecchi @MattGalsky editorial looking at bladder preservation evidence the caveats, and what we still need to prove before cystectomy can truly be avoided .. not there yet but systematic and multi biomarker/imaging approach to selection maybe 🔑 @EUplatinum @BladderCancerUS

[Laura Bukavina @LauraBukavinaMD]

@DrYukselUrun 😆

[Katy Beckermann @katy_beckermann]

Dolly Parton's name is in the funding acknowledgments of a 2020 NEJM paper on mRNA-1273, right next to NIAID 🎶

🔬 $1M in April 2020, which paid for the assay that first showed the vaccine was generating an immune response
🧬 Another $1M in 2022 for pediatric infectious disease, including infections in kids with cancer
📚 332 million free children’s books since 1995
🏔️ approx 9 million into Sevier County after the 2016 Gatlinburg fires

"I just see a need and if I can fill it, then I will." 💕

#Tennessee #MedTwitter #DollyParton

[Dr. Bishoy M. Faltas @FaltasLab]

Exciting and very timely for #IBCG26. Excited to be part of this important group contributing to this consensus paper. Thanks @shilpaonc and @UroDocAsh for your leadership